| scholarly article | Q13442814 |
| P50 | author | Sylvia Plevritis | Q89453368 |
| Jan van Riggelen | Q84411286 | ||
| P2093 | author name string | Arvin M Gouw | |
| Dean W Felsher | |||
| Tahera Zabuawala | |||
| Stacey J Adam | |||
| Ramya Parameswaran | |||
| Alper Yetil | |||
| Benedict Anchang | |||
| P2860 | cites work | Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells | Q28201183 |
| Tumor suppression by Ink4a-Arf: progress and puzzles | Q28207959 | ||
| ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence | Q28591778 | ||
| Cancer. Addiction to oncogenes--the Achilles heal of cancer | Q29614243 | ||
| Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF | Q29619663 | ||
| Long-term haematopoietic reconstitution by Trp53-/-p16Ink4a-/-p19Arf-/- multipotent progenitors | Q33328820 | ||
| Sumoylation induced by the Arf tumor suppressor: a p53-independent function | Q33821331 | ||
| Reversible tumorigenesis by MYC in hematopoietic lineages | Q33874286 | ||
| Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages | Q33933240 | ||
| Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor | Q33961286 | ||
| MYC Inactivation Elicits Oncogene Addiction through Both Tumor Cell-Intrinsic and Host-Dependent Mechanisms | Q34248882 | ||
| Regulation of cellular senescence by p53. | Q34254621 | ||
| CD4+ T Cells Contribute to the Remodeling of the Microenvironment Required for Sustained Tumor Regression upon Oncogene Inactivation | Q34346803 | ||
| Egr1 mediates p53-independent c-Myc-induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism | Q34490491 | ||
| Loss of p53 impedes the antileukemic response to BCR-ABL inhibition | Q34585293 | ||
| Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. | Q35133764 | ||
| Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis | Q35208288 | ||
| INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. | Q35208402 | ||
| Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction | Q35409292 | ||
| Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation | Q35928960 | ||
| Tumor escape in a Wnt1-dependent mouse breast cancer model is enabled by p19Arf/p53 pathway lesions but not p16 Ink4a loss | Q36183595 | ||
| p53-Dependent and -independent functions of the Arf tumor suppressor | Q36547718 | ||
| ARF represses androgen receptor transactivation in prostate cancer | Q36714871 | ||
| RasV12-mediated down-regulation of CCAAT/enhancer binding protein beta in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence | Q37219345 | ||
| Tumor dormancy and oncogene addiction | Q37286246 | ||
| Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression | Q37344073 | ||
| Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. | Q37351577 | ||
| Tumor suppression by ARF: gatekeeper and caretaker | Q37656961 | ||
| The ARF tumor suppressor: structure, functions and status in cancer | Q37765233 | ||
| Pro-senescence therapy for cancer treatment | Q37893959 | ||
| The Myc/macrophage tango: oncogene-induced senescence, Myc style | Q37948501 | ||
| p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein | Q38287966 | ||
| RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. | Q38906649 | ||
| Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5. | Q39030003 | ||
| The Arf tumor suppressor protein inhibits Miz1 to suppress cell adhesion and induce apoptosis | Q39785267 | ||
| C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells | Q39954044 | ||
| p14ARF directly interacts with Myc through the Myc BoxII domain | Q40330377 | ||
| Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Münster Group 87. | Q40376592 | ||
| p19ARF directly and differentially controls the functions of c-Myc independently of p53. | Q40516548 | ||
| Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc. | Q40544963 | ||
| The tumor suppressor ARF regulates innate immune responses in mice | Q42497602 | ||
| Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia. | Q51028662 | ||
| Genomic alterations of the p19ARF encoding exons in T-cell acute lymphoblastic leukemia. | Q52528881 | ||
| Aberrant methylation of p14ARF gene correlates with poor survival in osteosarcoma. | Q54623978 | ||
| Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias | Q68797680 | ||
| A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy | Q74117541 | ||
| Sustained loss of a neoplastic phenotype by brief inactivation of MYC | Q74413944 | ||
| Genomically complex lymphomas undergo sustained tumor regression upon MYC inactivation unless they acquire novel chromosomal translocations | Q78762284 | ||
| p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue | Q81805963 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cellular senescence | Q9075999 |
| P304 | page(s) | 3563-3577 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | p19ARF is a critical mediator of both cellular senescence and an innate immune response associated with MYC inactivation in mouse model of acute leukemia | |
| P478 | volume | 6 |
| Q42061306 | ARF: connecting senescence and innate immunity for clearance |
| Q47129670 | DNMT3B overexpression contributes to aberrant DNA methylation and MYC-driven tumor maintenance in T-ALL and Burkitt's lymphoma |
| Q40216791 | Globule Leukocytes and Other Mast Cells in the Mouse Intestine |
| Q39231572 | Menin Plays a Critical Role in the Regulation of the Antigen-Specific CD8+ T Cell Response upon Listeria Infection. |
| Q52728139 | The MYC oncogene is a global regulator of the immune response. |
| Q37687082 | Tumor suppressor ARF regulates tissue microenvironment and tumor growth through modulation of macrophage polarization. |
Search more.